Is it safe to take Gas-X or Pepto-Bismol while on GLP-1 medications
MASH is a more severe form of MASLD, or metabolic dysfunctionassociated steatotic liver disease, formerly known as nonalcoholic fatty liver disease (NAFLD)
It is associated with pineal gland modulation, telomerase activation in laboratory models, and improvements in sleep and circadian rhythm
In contrast, in 2018, the long-acting GIPGLP-1 co-agonist tirzepatide was found to have substantial glucose-lowering and weight loss properties, to a greater extent than that achieved by GLP-1R agonism with dulaglutide [68], findings replicated in Phase III trials comparing tirzepatide with semaglutide in people with type 2 diabetes [69]
While the DIY Semaglutide trend may stem from accessibility and cost-saving motivations, it comes with significant risks